Shareholding27 Oct 2026, 10:59 am
Chandra Bhagat Pharma: Samir Ramkant Dave Acquires 8 Lakh Warrants
AI Summary
Chandra Bhagat Pharma Ltd has received a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, from Samir Ramkant Dave. Dave has acquired 8,00,000 convertible warrants, which are convertible into equity shares, through a preferential issue. This acquisition increases the total diluted share capital of the company to 1,41,45,056 equity shares. The transaction is a significant step in the potential increase of stake by Mr. Dave in the company.
Key Highlights
- Samir Ramkant Dave acquired 8,00,000 convertible warrants.
- Acquisition was made via preferential allotment.
- Warrants are convertible into equity shares.
- Total diluted share capital increased to 1,41,45,056 shares.
Price Impact
More from CBPL